XtalPi Technology Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Public

  • Employees
  • 809

Employees

  • Stock Symbol
  • 02228

Stock Symbol

  • Investments
  • 19

  • Share Price
  • $0.74
  • (As of Monday Closing)

XtalPi Technology General Information

Description

XtalPi Holdings Ltd is an research platform company powered by artificial intelligence (AI) and robotics. It is dedicated to driving intelligent and digital transformation in the life sciences and materials sciences sectors. The company combines quantum physics, AI, cloud computing, and large-scale robotics to provide research & development solutions, services, and products for pharmaceuticals, biotechnology, renewable energy, and materials industries globally. The company has single segment that is intelligent robotics solutions and drug discovery solutions (including one-stop drug discovery solutions).

Contact Information

Website
www.xtalpi.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • The third floor of the second phase of the International Biomedical Industrial Park
  • Number 2 Hongliu Road, Futian District
  • Shenzhen, Guangdong 518000
  • China
+86 0755
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare Services
Stock Exchange
HKG
Corporate Office
  • The third floor of the second phase of the International Biomedical Industrial Park
  • Number 2 Hongliu Road, Futian District
  • Shenzhen, Guangdong 518000
  • China
+86 0755

XtalPi Technology Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XtalPi Technology Stock Performance

As of 14-Jul-2025, XtalPi Technology’s stock price is $0.74. Its current market cap is $2.97B with 4.02B shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.74 $0.71 $0.39 - $2.08 $2.97B 4.02B 92.7M -$0.11

XtalPi Technology Financials Summary

As of 31-Dec-2024, XtalPi Technology has a trailing 12-month revenue of $37.1M.

In Thousands,
USD
TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 2,192,413 2,192,413
Revenue 37,131 37,131 24,653 19,801
EBITDA (198,494) (198,494) (265,406) (210,008)
Net Income (211,360) (211,360) (270,589) (213,601)
Total Assets 596,532 596,532 565,091 625,586
Total Debt 20,378 20,378 36,109 18,763
Public Fundamental Data provided by Morningstar, Inc. disclaimer

XtalPi Technology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore XtalPi Technology‘s full profile, request access.

Request a free trial

XtalPi Technology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
XtalPi Holdings Ltd is an research platform company powered by artificial intelligence (AI) and robotics. It is dedicate
Other Healthcare Technology Systems
Shenzhen, China
809 As of 2024

Boston, MA
 

Menlo Park, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

XtalPi Technology Competitors (25)

One of XtalPi Technology’s 25 competitors is InSilico Medicine, a Venture Capital-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSilico Medicine Venture Capital-Backed Boston, MA
Strateos Venture Capital-Backed Menlo Park, CA
BenevolentAI Formerly PE-Backed London, United Kingdom
Vium Formerly VC-backed San Mateo, CA
Iktos Venture Capital-Backed Paris, France
You’re viewing 5 of 25 competitors. Get the full list »

XtalPi Technology Patents

XtalPi Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250076327-A1 Sample preparation workstation and sample preparation system Pending 15-Jul-2022
US-20240167916-A1 Powder sample adding device and powder sample adding system Pending 29-Jun-2022
US-20240123634-A1 Gripper, clamping device having the same and mobile robot Pending 22-Jun-2022
US-20240288463-A1 Solvent storage device and liquid transfer system Pending 14-Jun-2022
EP-4482839-A2 Stimulator of interferon genes (sting) modulators, and compositions and methods thereof Pending 21-Feb-2022 C07D498/04
To view XtalPi Technology’s complete patent history, request access »

XtalPi Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

XtalPi Technology Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore XtalPi Technology‘s full profile, request access.

Request a free trial

XtalPi Technology Investments & Acquisitions (19)

XtalPi Technology’s most recent deal was a Merger/Acquisition with LCC Therapeutics. The deal was made on 12-Jun-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
LCC Therapeutics 12-Jun-2025 Merger/Acquisition Biotechnology
Siwei Medical 13-May-2025 Merger/Acquisition Other Healthcare Services
Xellar Biosystems 28-Apr-2025 Early Stage VC Biotechnology
NewDEL Biotech 12-Mar-2025 Early Stage VC Drug Discovery
FutureBio 27-Feb-2025 Early Stage VC Other Commercial Products
You’re viewing 5 of 19 investments and acquisitions. Get the full list »

XtalPi Technology ESG

Risk Overview

Risk Rating

Updated February, 01, 2025

39.06 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,697

Rank

Percentile

Pharmaceuticals

Industry

of 847

Rank

Percentile

Biotechnology

Subindustry

of 368

Rank

Percentile

To view XtalPi Technology’s complete esg history, request access »

XtalPi Technology Exits (1)

XtalPi Technology’s most recent exit was on 12-Jun-2025 from LCC Therapeutics. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
LCC Therapeutics 12-Jun-2025 Completed
To view XtalPi Technology’s complete exits history, request access »

XtalPi Technology Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
LCC Therapeutics Wigan, United Kingdom 2014
Siwei Medical Shanghai, China 2008

XtalPi Technology FAQs

  • When was XtalPi Technology founded?

    XtalPi Technology was founded in 2015.

  • Where is XtalPi Technology headquartered?

    XtalPi Technology is headquartered in Shenzhen, China.

  • What is the size of XtalPi Technology?

    XtalPi Technology has 809 total employees.

  • What industry is XtalPi Technology in?

    XtalPi Technology’s primary industry is Other Healthcare Technology Systems.

  • Is XtalPi Technology a private or public company?

    XtalPi Technology is a Public company.

  • What is XtalPi Technology’s stock symbol?

    The ticker symbol for XtalPi Technology is 02228.

  • What is the current stock price of XtalPi Technology?

    As of 14-Jul-2025 the stock price of XtalPi Technology is $0.74.

  • What is the current market cap of XtalPi Technology?

    The current market capitalization of XtalPi Technology is $2.97B.

  • What is XtalPi Technology’s current revenue?

    The trailing twelve month revenue for XtalPi Technology is $37.1M.

  • Who are XtalPi Technology’s competitors?

    InSilico Medicine, Strateos, BenevolentAI, Vium, and Iktos are some of the 25 competitors of XtalPi Technology.

  • What is XtalPi Technology’s annual earnings per share (EPS)?

    XtalPi Technology’s EPS for 12 months was -$0.11.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »